Bristol-Myers Squibb

American pharmaceutical company

BMY NYSE ISIN US1101221083 SEC CIK 14272 LEI HLYYNH7UQUORYSJQCN42
Follow Bristol-Myers Squibb Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $13.1B +6.9% vs same quarter last year
Net income $2.2B −1.8% vs same quarter last year
EPS, diluted $1.05 −2.8% vs same quarter last year
Operating cash flow $4.2B −33.8% vs same quarter last year
Revenue by quarter
$12.3B
$11.2B
$12.3B
$12.2B
$12.5B
$11.5B
$13B
$13.1B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20B$0$20B$40B$60BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$48.2B$7.1B
FY24$48.3B−$8.9B
FY23$45B$8B
FY22$46.2B$6.3B
FY21$46.4B$7B
FY20$42.5B−$9B
FY19$26.1B$3.4B
FY18$22.6B$4.9B
FY17$20.8B$1B
FY16$19.4B$4.5B
FY15$16.6B$1.6B
FY14$15.9B$2B
FY13$16.4B$2.6B
FY12$17.6B$2B
FY11$21.2B$3.7B
MarginsShare of revenue
  • Gross margin
  • Net margin
−25%0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginNet margin
FY2571.1%14.6%
FY2471.1%−18.5%
FY2376.2%17.8%
FY2278%13.7%
FY2178.6%15.1%
FY2072.3%−21.2%
FY1969.1%13.2%
FY1871.3%21.8%
FY1770.7%4.8%
FY1674.5%22.9%
FY1576.4%9.5%
FY1475.2%12.6%
FY1371.8%15.6%
FY1273.8%11.1%
FY1173.6%17.5%
Free cash flowOperating cash flow minus capital expenditure
$0$5B$10B$15B$20BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$12.8B
FY24$13.9B
FY23$12.7B
FY22$11.9B
FY21$15.2B
FY20$13.3B
FY19$7.4B
FY18$6.1B
FY17$4.2B
FY16$1.8B
FY15$1.3B
FY14$2.6B
FY13$3B
FY12$6.4B
FY11$4.5B
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$5B$10B$15BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$5B$0
FY24$4.9B$0
FY23$4.7B$5.2B
FY22$4.6B$8B
FY21$4.4B$6.3B
FY20$4.1B$1.5B
FY19$2.7B$7.3B
FY18$2.6B$320M
FY17$2.6B$2.5B
FY16$2.5B$231M
FY15$2.5B-
FY14$2.4B-
FY13$2.3B$433M
FY12$2.3B$2.4B
FY11$2.3B$1.2B
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Bristol-Myers Squibb
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBristol-Myers SquibbHealthcare median
FY2514.6%−30.6%
FY24−18.5%−47%
FY2317.8%−58%
FY2213.7%−80.4%
FY2115.1%−71.9%
FY20−21.2%−62.2%
FY1913.2%−46.3%
FY1821.8%−49.6%
FY174.8%−45.9%
FY1622.9%−36%
FY159.5%−38.4%
FY1412.6%−35.5%
FY1315.6%−37.1%
FY1211.1%−29.1%
FY1117.5%−27.9%